"Aminoquinolines" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Quinolines substituted in any position by one or more amino groups.
| Descriptor ID |
D000634
|
| MeSH Number(s) |
D03.633.100.810.050
|
| Concept/Terms |
|
Below are MeSH descriptors whose meaning is more general than "Aminoquinolines".
Below are MeSH descriptors whose meaning is more specific than "Aminoquinolines".
This graph shows the total number of publications written about "Aminoquinolines" by people in this website by year, and whether "Aminoquinolines" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1991 | 2 | 4 | 6 |
| 1992 | 1 | 1 | 2 |
| 1993 | 1 | 2 | 3 |
| 1994 | 1 | 1 | 2 |
| 1995 | 4 | 0 | 4 |
| 1996 | 1 | 1 | 2 |
| 1997 | 2 | 1 | 3 |
| 1998 | 2 | 3 | 5 |
| 1999 | 1 | 4 | 5 |
| 2000 | 5 | 2 | 7 |
| 2001 | 2 | 5 | 7 |
| 2002 | 19 | 5 | 24 |
| 2003 | 26 | 8 | 34 |
| 2004 | 21 | 10 | 31 |
| 2005 | 28 | 4 | 32 |
| 2006 | 37 | 16 | 53 |
| 2007 | 47 | 20 | 67 |
| 2008 | 44 | 22 | 66 |
| 2009 | 45 | 23 | 68 |
| 2010 | 41 | 23 | 64 |
| 2011 | 48 | 34 | 82 |
| 2012 | 55 | 27 | 82 |
| 2013 | 41 | 30 | 71 |
| 2014 | 63 | 39 | 102 |
| 2015 | 44 | 31 | 75 |
| 2016 | 55 | 42 | 97 |
| 2017 | 50 | 40 | 90 |
| 2018 | 23 | 30 | 53 |
| 2019 | 11 | 7 | 18 |
| 2020 | 2 | 1 | 3 |
To return to the timeline, click here.
Below are the most recent publications written about "Aminoquinolines" by people in Profiles.
-
Potential therapeutic targets for combating SARS-CoV-2: Drug repurposing, clinical trials and recent advancements. Life Sci. 2020 Sep 01; 256:117883.
-
A systematic review on use of aminoquinolines for the therapeutic management of COVID-19: Efficacy, safety and clinical trials. Life Sci. 2020 Aug 01; 254:117775.
-
[Potential harms associated with 4-aminoquinoline treatment]. Lakartidningen. 2020 04 23; 117.
-
Tafenoquine: the new kid on the block. Curr Opin Infect Dis. 2019 10; 32(5):407-412.
-
Design, synthesis and biological evaluation of 4-aminoquinoline-guanylthiourea derivatives as antimalarial agents. Bioorg Chem. 2019 10; 91:103094.
-
Host cell Rac1 GTPase facilitates Toxoplasma gondii invasion. Sci China Life Sci. 2020 Apr; 63(4):610-612.
-
Ferroquine-derived polyamines that target resistant Plasmodium falciparum. Eur J Med Chem. 2019 Oct 01; 179:78-83.
-
Tafenoquine: integrating a new drug for malaria prophylaxis into travel medicine practice. J Travel Med. 2019 06 01; 26(4).
-
Safety, Efficacy, and Biomarker Analysis of Pyrotinib in Combination with Capecitabine in HER2-Positive Metastatic Breast Cancer Patients: A Phase I Clinical Trial. Clin Cancer Res. 2019 09 01; 25(17):5212-5220.
-
Development of Potent and Selective Pyrazolopyrimidine IRAK4 Inhibitors. J Med Chem. 2019 07 11; 62(13):6223-6240.